EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›TLPH

TLPH

TALPHERA, INC.

Next earnings Aug 12, 2026 · consensus $-0.07 EPS

Last earnings +5.1% on 2026-05-13

Sell
$1.03
▼ -3.74%
$1.03▲ +134.09%
over 1Y
L $0.39EODHDH $1.46
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today-3.7%
1W+4.9%
1M+25.7%
3M+38.9%
YTD-11.2%
1Y+134.1%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Sell
Quality
F
Valuation
Fair value
Filings
Flagged
Sell
Conviction
Horizon
Medium (3–12mo)
Street · 8 analysts
Buy

Conservative balance sheet (liabilities/equity 0.74x); but unprofitable (net margin -51035.7%).

Revenue (FY2025) $28.0K · FY2025

TALPHERA, INC. shows $28.0K in FY2025 revenue, a -51035.7% net margin, and -83.9% ROE.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$2.82M$0.00$651K$0.00$28.0K
Gross profit—————
Operating income-$36.0M-$25.3M-$16.9M-$15.3M-$13.5M
Net income-$35.1M$47.8M-$18.4M-$13.0M-$14.3M
Diluted EPS-$5.86$5.72-$1.29——
Net margin-1245.5%—-2826.0%—-51035.7%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$45.7M
EV / EBITDA—
EV / Sales1630.6
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-27.7%
FCF yield-22.0%

Quality & risk

ROIC (est.)-62.5%
Free cash flow-$11.4M
Total debt$0.00
Net cash$5.89M
Altman Z-Score-20.58 distress
Piotroski F-Score5/8

Capital returns

Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+192.7%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Red flag in recent filings — delisting notice (2026-03-13). Worth a closer look.
  1. 8-K Officer / director change2026-06-23
  2. 8-K Earnings results2026-05-13
  3. 10-Q Quarterly report2026-05-13
  4. DEF 14A Proxy statement2026-04-29
  5. S-3 Shelf registration (potential raise)2026-03-25
  6. 8-K Earnings results2026-03-23
  7. 10-K Annual report2026-03-23
  8. 8-K Unregistered share sales2026-03-16
  9. 8-K Delisting notice2026-03-13

Recent filings

all on EDGAR ↗
4Period ending 2026-06-222026-06-24open ↗4Period ending 2026-06-222026-06-24open ↗4Period ending 2026-06-222026-06-24open ↗4Period ending 2026-06-222026-06-24open ↗4Period ending 2026-06-222026-06-24open ↗4Period ending 2026-06-222026-06-24open ↗4Period ending 2026-06-222026-06-24open ↗8-KPeriod ending 2026-06-222026-06-23open ↗4Period ending 2026-05-202026-05-21open ↗SCHEDULE 13G/AFiling2026-05-15open ↗10-QPeriod ending 2026-03-312026-05-13open ↗8-KPeriod ending 2026-05-132026-05-13open ↗

Quality score

F
ValueGrowthProfitHealthMom.
ValueF
GrowthF
ProfitabilityF
Financial healthC+
Momentum—
  • ✗Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
  • ✓Liabilities below 2× equity
Revenue
$28.0K
Net margin
-51035.7%
ROE
-83.9%
P/E
—

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$28.0K
Net income-$14.3M-9.9%
Operating income-$13.5M+11.6%
Diluted EPS-$1.29-122.6%
Cash & equivalents$5.89M-33.5%
Total assets$29.7M+63.0%
Total liabilities$12.7M+23.9%
Stockholders' equity$17.0M+112.9%
Op.: -48157.1%L/E: 0.74x

Frequently asked

Is TALPHERA, INC. (TLPH) a buy?
TLPH currently carries a Sell rating with 3/5 conviction, derived from its latest SEC filings. Conservative balance sheet (liabilities/equity 0.74x); but unprofitable (net margin -51035.7%).
What is TALPHERA, INC.'s quality score?
TLPH scores 33.8235294117647/100 (grade F) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001427925, latest 10-Q filed 2026-05-13) · EODHD · as of 6/26/2026, 7:22:24 PM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2026-06-22
WAN MARK A
Director
Award5.10K
2026-06-22
Todisco Joseph
Director
Award5.10K
2026-06-22
JAIN ABHINAV
Director
Award5.10K
2026-06-22
HOFFMAN STEPHEN J
Director
Award5.10K
2026-06-22
Broadfoot Jill Marie
Director
Award5.10K
2026-06-22
Bozilenko Marina
Director
Award5.10K
2026-06-22
ADAMS ADRIAN
Director
Award5.10K
2026-05-20
Aslam Shakil
Chief Medical Officer
Tax4.52K @ $0.82$3.72K

Earnings history

beat/miss · move
2026-05-13Beat +44.0% est▲ +5.11%8-K ↗
2026-03-23Beat +26.5% est▼ -3.81%8-K ↗
2025-11-12Beat +23.0% est▲ 0.00%8-K ↗
2025-08-14Beat +2.0% est▲ 0.00%8-K ↗
2025-05-14—▼ -1.92%8-K ↗
2025-03-31—▼ -15.25%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Recent news

market news →
Earnings Scheduled For May 13, 2026Bullish
finance.yahoo.com· 2026-05-13
Talphera GAAP EPS of -$0.11 in-lineBullish
seekingalpha.com· 2025-11-12
Talphera files prospectus for resale of up to 30.9M shares by selling stockholdersBullish
seekingalpha.com· 2025-09-22
Let's take a look at the stocks that are in motion in today's session.Bullish
chartmill.com· 2025-09-09
Talphera Announces $29 Mln Private Placement Led By CorMedix And Institutional InvestorsBullish
nasdaq.com· 2025-09-09
Top movers analysis one hour before the close of the markets on 2025-09-08: top gainers and losers in today's session.Bullish
chartmill.com· 2025-09-08

Vs tracked universe

compare →

1044 tracked peers · median

EDGAR Score34 vs 67
Revenue growth— vs 7.1%
Net margin-51035.7% vs 10.5%
Return on equity-83.9% vs 12.3%
P/E— vs 25.5